CBRE Q1 2026 Earnings Strong EPS Beat Amid Resilient Commercial Real Estate Market Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain FHN Q1 2026 Earnings EPS Beats Estimates by 62 Stock Edges Lower on Caution GRRR Q4 2025 Earnings Significant EPS Miss but Stock Rises Over 12 Turn Therapeutics Inc TTRX Q1 2026 Earnings Narrow EPS Miss Overshadowed by Operational Progress Costamare Inc CMRE Q1 2026 Earnings EPS Misses Estimates as Stock Declines 42